Clinical Study

Neossance® Squalane, Skin Therapy Benefits

Format: PDF file | Document type: Clinical Study | Promoted Content

This Clinical Study has been written by APRINNOVA – A joint venture of AMYRIS and NIKKOL Group , and any views and opinions expressed do not necessarily reflect those of


Aprinnova is leading a resurgence in Squalane, reducing supply fears while making it attractive to use in mass/value positioned brands. Aprinnova is addressing formulator’s needs for skin therapy benefits, exceptional emolliency, supply security and costs that enable use in value positioned brands with the introduction and support of its Neossance®​ Squalane. Brands are benefiting by the ability to craft new and more powerful claims to support consumer acceptance while broadening the use of Squalane. Our brochure details our responsible sustainable process, clinical and consumer data that support skin therapy benefits and claims, and the wide range of applications where Squalane adds value.

Related resources from APRINNOVA – A joint venture of AMYRIS and NIKKOL Group

Supplier info centre